QSAR study on pyridinone derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitor: A mixed approach

Medicinal Chemistry

Volumn 3, Issue 3, 2007, Pages 227-232

  Vasanthanathan, P ^a   Lakshmi, M ^a   Ragguram Rao, A ^b  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

AIDS; Hansch analysis; Hydrophobic constant; Non nucleoside; Pyridinone derivatives; QSAR

Indexed keywords

AROMATIC COMPOUND; PYRIDONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; EXTERNAL VALIDITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; INTERNAL VALIDITY; MODEL; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MODELS, MOLECULAR; PYRIDONES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 34248652703     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340607780620617     Document Type: Article

References (19)

1. Barre-sinoossi, F.; Chermann, J.C.; Rey, F.; Nugergre, M.T.; Chamaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Vezinet-Brun, F.; Rouziouz, C.; Rozenbaum, W.; Montagnier, L. Science, 1983, 220, 868.
2. Popovic, M.; Sarngadharan, M.G.; Read, E.; Gallo, R.C. Science, 1984, 224, 497.
3. Clavel, F.; Guyader, M.; Guetard, D.; Salle, M.; Montagnier, L.; Alizon, M. Nature, 1986, 324, 891
4. Guyader, M.; Emerman, M.; Sonigo, P.; Clavel, F.; Montagnier, L.; Alizon, M. Nature, 1987,326, 662.
5. Embretson, J.; Zupancic, M.; Ribas, J.L.; Burke, L.; Racz, P.; Tenner-Racz, K.; Haase, A. T. Nature, 1993, 362, 359.
6. De Clercq, E. II Farmaco, 1999 54, 26.
7. http:/www.niaid.nih.gov/daids/dtpdb/fdadrug.htm
8. Garg, R.; Gupta, S.P.; Gao, H.; Babu, M.S.; Debnath, A.K.; Hansch. C. Chem. Rev. 1999,99, 3525.
9. De Clercq, E. Med. Res. Rev. 1993,13, 229.
10. De Clercq, E. Exp. Opin. Invest. Drugs, 1994,3, 253.
11. Vasanthanathan P.; Lakshmi M.; Arockia babu. M; Gupta. A.K.; Kaskhedikar. S.G. Chem. Pharm. Bull., 2006, 54(4), 583.
12. Lakshmi, M; Dixit, A; Saxena, A.K. Indian J. Chem, 2006, 45A, 34.
13. Vasanthanathan P.; Lakshmi M.; Arockia babu. M; Kaskhedikar. S. G. Bio. Pharm. Bull., 2006 29(6), 1262.
14. Vasanthanathan P.; Lakshmi M.; Arockia. babu. M; Kaskhedikar. S. G. Med. Chem., 2006, 2(4), 363.
15. Hoffman, J.M.; Smith, A.M.; Rooney, C.S.; Fisher, T.E.; Wai, J.S.; Thomas, C.M.; Bamberger, D.L.; Barnes, J.L.; Williams, T. M.; Jones, J.H.; Olson, S.D.; O'Brien, J.A.; Goldman, M.E.; Nunberg, J.H.; Quintero, J.C.; Shileif, W.A.; Emini, E.A.; Anderson, P.S. J. Med. Chem., 1993,36, 953.
16. Kubinyi, H. QSAR Hansch and related approaches in methods and principles in medicinal chemistry, vol.1, VCH, Wienheim., 1993
17. Hansch C., Leo A., Exploring QSAR - Fundamentals and Applications in Chemistry and Biology; Heller, S.R., Ed.; American Chemical Society: Washington, DC, 1995.
18. Wold, S.; Eriksson, L. Chemometric Methods in Molecular Design, Edited by Waterbeemd H van de (VCH, Weinheim), 1995, 321.
19. Gupta, A.K.; Arockia babu, M.; Kaskhedikar, S.G. Indian J. Pharm. Sci., 2004, 66, 396.